MKS Inc.

MKS Inc.

April 26, 2011 08:01 ET

Varian X-Ray Products Streamlines Engineering Processes for Flat-Panel Imaging Systems with MKS Integrity

WATERLOO, ONTARIO--(Marketwire - April 26, 2011) - MKS Inc. (MKS) (TSX:MKX) the global application lifecycle management (ALM) technology leader, today announced that Varian Medical Systems, Inc., a leading manufacturer of medical devices and a premier supplier of X-ray tubes and flat-panel image detectors for X-ray imaging, has selected MKS Integrity™ to streamline Varian's flat-panel engineering processes.

As with all organizations in the medical device industry, Varian is subject to U.S. federal and international regulations. Varian was searching for automated solutions to replace its manual processes and documents and increase management visibility. MKS Integrity is improving Varian's reporting to regulatory agencies, and assisting Varian in its aggressive business growth plan and time to market reduction efforts.

"MKS Integrity allows us to trace the relationship between requirements and other development artifacts in real-time so we can do impact analysis throughout our development cycle, helping us understand the progress we've made toward release readiness and compliance requirements. By managing engineering assets and documents with MKS Integrity, we have been able to generate reports and complete our regulatory submissions in a fraction of the time it took previously," said Keith Gray, Engineering Manager of Imaging Products at Varian.

Varian experienced a significant reduction in effort, reducing its cycle time, and automating requirements and test management, while providing risk analysis on a single platform. Varian's real-time traceability report capability gives management instant visibility into engineering release readiness.

"Our MKS Integrity solution may help other medical device companies automate their own risk assessment procedures, enabling development teams to efficiently design potential risks out of the system - speeding development, driving down costs, and reducing risk - all with the goal of getting safe, cutting-edge medical devices out to the consumer sooner," said Andrew Wertkin, CTO at MKS.

About MKS

MKS enables organizations to reduce the overwhelming complexity of developing software intensive products thereby removing barriers to rapid innovation.

MKS Integrity manages all systems and software development processes and connects all engineering artifacts, including requirements, models, code and tests, ensuring comprehensive lifecycle traceability. MKS Integrity's open architecture integrates disparate tools into a streamlined engineering process, allowing orchestration of engineering change and collaboration across the technology supply chain. With MKS Integrity, engineering teams improve productivity and quality, streamline compliance and gain complete product visibility, which ultimately drives more innovative products into the market.

With offices worldwide, MKS supports customers across industries including, Automotive, Aerospace and Defense, High Tech Electronics and Medical Devices. For more information about MKS and MKS Integrity, visit our web site at

Copyright © 2011 MKS Inc. MKS and MKS Integrity are trademarks of MKS Inc. All other trademarks mentioned in this release are the property of their respective owners.

This news release contains forward-looking statements that involve risks and uncertainties, which may cause actual results to differ materially from the statements made. When used in this document, the words "may", "would", "could", "will", "intend", "plan", "anticipate", "believe", "estimate", "expect" and similar expressions are intended to identify forward-looking statements. Such statements reflect the Company's current views with respect to future events and are subject to such risks and uncertainties. Many factors could cause our actual results to differ materially from the statements made including those factors detailed from time to time in filings made by the Company with Canadian securities regulatory authorities. Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward looking statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated or expected. Although the Company believes the expectations represented by such forward looking statements are reasonable, there can be no assurance that those expectations will prove to be correct. The Company does not intend and does not assume any obligation to update these forward-looking statements.

Contact Information